 | • レポートコード：MRC23Q36013 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の前頭側頭型認知症治療薬市場について調査・分析し、世界の前頭側頭型認知症治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（抗うつ剤、抗精神病薬）、用途別セグメント分析（病院薬局、小売店薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Sanofi S.A.、Novartis AG、F. Hoffmann-La Roche、AstraZeneca GmbH、Merck & Co.、Valeant Pharmaceutical International、Pfizerなどが含まれています。世界の前頭側頭型認知症治療薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、前頭側頭型認知症治療薬市場規模を推定する際に考慮しました。本レポートは、前頭側頭型認知症治療薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、前頭側頭型認知症治療薬に関するビジネス上の意思決定に役立てることを目的としています。 ・前頭側頭型認知症治療薬市場の概要 - 前頭側頭型認知症治療薬のタイプ別セグメント - 世界の前頭側頭型認知症治療薬市場規模：タイプ別分析（抗うつ剤、抗精神病薬） - 前頭側頭型認知症治療薬の用途別セグメント - 世界の前頭側頭型認知症治療薬市場規模：用途別分析（病院薬局、小売店薬局、その他） - 世界の前頭側頭型認知症治療薬市場規模予測（2018年-2029年） ・前頭側頭型認知症治療薬市場の成長トレンド - 前頭側頭型認知症治療薬の地域別市場規模（2018年-2029年） - 前頭側頭型認知症治療薬市場ダイナミクス - 前頭側頭型認知症治療薬の業界動向 - 前頭側頭型認知症治療薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：抗うつ剤、抗精神病薬 - 世界の前頭側頭型認知症治療薬のタイプ別市場規模（2018年-2023年） - 世界の前頭側頭型認知症治療薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院薬局、小売店薬局、その他 - 世界の前頭側頭型認知症治療薬の用途別市場規模（2018年-2023年） - 世界の前頭側頭型認知症治療薬の用途別市場規模（2024年-2029年） ・前頭側頭型認知症治療薬の地域別市場規模 - 北米の前頭側頭型認知症治療薬市場規模（2018年-2029年） - アメリカの前頭側頭型認知症治療薬市場規模（2018年-2029年） - ヨーロッパの前頭側頭型認知症治療薬市場規模（2018年-2029年） - アジア太平洋の前頭側頭型認知症治療薬市場規模（2018年-2029年） - 中国の前頭側頭型認知症治療薬市場規模（2018年-2029年） - 日本の前頭側頭型認知症治療薬市場規模（2018年-2029年） - 韓国の前頭側頭型認知症治療薬市場規模（2018年-2029年） - インドの前頭側頭型認知症治療薬市場規模（2018年-2029年） - オーストラリアの前頭側頭型認知症治療薬市場規模（2018年-2029年） - 中南米の前頭側頭型認知症治療薬市場規模（2018年-2029年） - 中東・アフリカの前頭側頭型認知症治療薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Sanofi S.A.、Novartis AG、F. Hoffmann-La Roche、AstraZeneca GmbH、Merck & Co.、Valeant Pharmaceutical International、Pfizer ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Frontotemporal Dementia Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Frontotemporal Dementia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Frontotemporal Dementia Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Frontotemporal Dementia Treatment in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Frontotemporal Dementia Treatment include Sanofi S.A., Novartis AG, F. Hoffmann-La Roche, AstraZeneca GmbH, Merck & Co., Valeant Pharmaceutical International and Pfizer, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Frontotemporal Dementia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frontotemporal Dementia Treatment.
The Frontotemporal Dementia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Frontotemporal Dementia Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Frontotemporal Dementia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sanofi S.A.
Novartis AG
F. Hoffmann-La Roche
AstraZeneca GmbH
Merck & Co.
Valeant Pharmaceutical International
Pfizer
Segment by Type
Antidepressants
Antipsychotics
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Frontotemporal Dementia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Frontotemporal Dementia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antidepressants
1.2.3 Antipsychotics
1.3 Market by Application
1.3.1 Global Frontotemporal Dementia Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Frontotemporal Dementia Treatment Market Perspective (2018-2029)
2.2 Frontotemporal Dementia Treatment Growth Trends by Region
2.2.1 Global Frontotemporal Dementia Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Frontotemporal Dementia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Frontotemporal Dementia Treatment Forecasted Market Size by Region (2024-2029)
2.3 Frontotemporal Dementia Treatment Market Dynamics
2.3.1 Frontotemporal Dementia Treatment Industry Trends
2.3.2 Frontotemporal Dementia Treatment Market Drivers
2.3.3 Frontotemporal Dementia Treatment Market Challenges
2.3.4 Frontotemporal Dementia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Frontotemporal Dementia Treatment Players by Revenue
3.1.1 Global Top Frontotemporal Dementia Treatment Players by Revenue (2018-2023)
3.1.2 Global Frontotemporal Dementia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Frontotemporal Dementia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Frontotemporal Dementia Treatment Revenue
3.4 Global Frontotemporal Dementia Treatment Market Concentration Ratio
3.4.1 Global Frontotemporal Dementia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Frontotemporal Dementia Treatment Revenue in 2022
3.5 Frontotemporal Dementia Treatment Key Players Head office and Area Served
3.6 Key Players Frontotemporal Dementia Treatment Product Solution and Service
3.7 Date of Enter into Frontotemporal Dementia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Frontotemporal Dementia Treatment Breakdown Data by Type
4.1 Global Frontotemporal Dementia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Frontotemporal Dementia Treatment Forecasted Market Size by Type (2024-2029)
5 Frontotemporal Dementia Treatment Breakdown Data by Application
5.1 Global Frontotemporal Dementia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Frontotemporal Dementia Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Frontotemporal Dementia Treatment Market Size (2018-2029)
6.2 North America Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
6.4 North America Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Frontotemporal Dementia Treatment Market Size (2018-2029)
7.2 Europe Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
7.4 Europe Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Frontotemporal Dementia Treatment Market Size (2018-2029)
8.2 Asia-Pacific Frontotemporal Dementia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Frontotemporal Dementia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Frontotemporal Dementia Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Frontotemporal Dementia Treatment Market Size (2018-2029)
9.2 Latin America Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
9.4 Latin America Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Frontotemporal Dementia Treatment Market Size (2018-2029)
10.2 Middle East & Africa Frontotemporal Dementia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Frontotemporal Dementia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Frontotemporal Dementia Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Detail
11.1.2 Sanofi S.A. Business Overview
11.1.3 Sanofi S.A. Frontotemporal Dementia Treatment Introduction
11.1.4 Sanofi S.A. Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.1.5 Sanofi S.A. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Frontotemporal Dementia Treatment Introduction
11.2.4 Novartis AG Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.2.5 Novartis AG Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Frontotemporal Dementia Treatment Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 AstraZeneca GmbH
11.4.1 AstraZeneca GmbH Company Detail
11.4.2 AstraZeneca GmbH Business Overview
11.4.3 AstraZeneca GmbH Frontotemporal Dementia Treatment Introduction
11.4.4 AstraZeneca GmbH Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.4.5 AstraZeneca GmbH Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Frontotemporal Dementia Treatment Introduction
11.5.4 Merck & Co. Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.5.5 Merck & Co. Recent Development
11.6 Valeant Pharmaceutical International
11.6.1 Valeant Pharmaceutical International Company Detail
11.6.2 Valeant Pharmaceutical International Business Overview
11.6.3 Valeant Pharmaceutical International Frontotemporal Dementia Treatment Introduction
11.6.4 Valeant Pharmaceutical International Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.6.5 Valeant Pharmaceutical International Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Frontotemporal Dementia Treatment Introduction
11.7.4 Pfizer Revenue in Frontotemporal Dementia Treatment Business (2018-2023)
11.7.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details